FDA Inspection 1062620 — Aeon Astron Europe B.V.

Aeon Astron Europe B.V. — FEI 3007676875

The FDA completed an inspection of Aeon Astron Europe B.V. on July 19, 2018 in Leiden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Leiden (Netherlands)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures